Upholding ethical MedTech standards is vital for ensuring transparency, responsibility, and trust between the medical technology industry, healthcare professionals, and patients. The compliance status granted to the 46th SICOT Congress 2026 demonstrates the congress’s commitment to ethical business practices, independent scientific exchange, and responsible collaboration across the healthcare community.

Compliance with the MedTech Europe Code of Ethical Business Practice helps protect the integrity and reputation of all stakeholders involved while ensuring that patient welfare remains the highest priority. It also supports transparency, reduces legal and reputational risks, harmonises standards across Europe and beyond, and promotes responsible engagement in key areas such as medical education, scientific research, and professional development.

The 46th SICOT Congress 2026, taking place from 29 September to 1 October 2026 in Kyoto, Japan, has successfully met the MedTech Europe Conference Vetting System (CVS) requirements and has been assessed as Compliant across all evaluation criteria.